Appendix 4E Variance Report
Filed with ASX · · 1 page · English
Summary by 6ix AI
It explains adjustments made following an independent valuation related to the acquisition of Reliis Pty Ltd. The report highlights changes in administration expenses, goodwill, intangibles, and reserves due to the finalization of acquisition accounting. These adjustments reflect a revised fair value assessment impacting the financial position of the company.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Patrys
- Annual Report - 30 June 2025
- Appendix 4G and Corporate Governance Statement
- First Participants Dosed in RLS-2202 Phase 1A Clinical Trial
- PAB Establishes Clinical Advisory Committee
- Appendix 4E - Preliminary Final Report
Later from Patrys
- Patrys Completes Cohort 1 Dosing and Follow-Up
- Notification of cessation of securities - PAB
- Date of AGM and Closing Date for Director Nominations
- Investor Webinar
- Investor Presentation
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys